Author:
Massey Conner J.,Hink Eric,Kingdom Todd T.
Publisher
Springer Science and Business Media LLC
Subject
Neurology (clinical),Otorhinolaryngology,Immunology and Allergy,Surgery
Reference25 articles.
1. •• Kingdom TT, Davies BW, Durairaj VD. Orbital decompression for the management of thyroid eye disease: an analysis of outcomes and complications. Laryngoscope. 2015;125:2034–40 Describes proper technique for balanced endoscopic orbital decompression and excellent surgical outcomes.
2. Burch HB, Wartofsky L. Graves’ ophthalmopathy: current concepts regarding pathogenesis and management. Endocr Rev. 1993;14:747–93.
3. Forbes G, Gorman CA, Brennan MD, Gehring DG, Ilstrup DM, Earnest F. Ophthalmopathy of graves’ disease: computerized volume measurements of the orbital fat and muscle. AJNR Am J Neuroradiol. 1986;7:651–6.
4. Grubeck-Loebenstein B, Trieb K, Sztankay A, Holter W, Anderl H, Wick G. Retrobulbar T cells from patients with graves’ ophthalmopathy are CD8+ and specifically recognize autologous fibroblasts. J Clin Invest. 1994;93:2738–43.
5. Kahaly GJ, Pitz S, Hommel G, Dittmar M. Randomized, single blind trial of intravenous versus oral steroid monotherapy in graves’ orbitopathy. J Clin Endocrinol Metab. 2005;90:5234–40.